Re: fetal cells in maternal blood

From: T-H Bui, Clinical Genetics, Karolinska Hospital (bui@gen.ks.se)
Thu May 30 04:06:25 1996


At 12.56 1996-05-28 -0500, charlie chambers wrote: >Both MACS and FACS technologies are part of the current NIH funded
>multi-center study. The group most experienced with MACS would be from
>Germany. I would suggest you contact Wolfgang Holzgreve regarding this
>issue at the University of Muenster.
>

Just a comment: Prof. Wolfgang Holzgreve has moved for more than a year ago to the University of Basel in Switzerland. If interested of his address etc. please contact me directly.

***************************************************************** The-Hung Bui, M.D. Associate Head Physician

--
Department of Clinical Genetics
Karolinska Hospital
S-171 76 Stockholm, Sweden

phone: +46 8 729 4989 or 729 2472 (secretary) fax: +46 8 32 77 34 E-mail: bui@gen.ks.se or The-Hung.Bui@molmed.ki.se ******************************************************************





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Mon Nov 2 05:18:27 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.